157 related articles for article (PubMed ID: 22611701)
1. [The use of different forms of naltrexone in the treatment of opioid dependence].
Krupitskiĭ EM; Zvartau EE; Blokhina EA; Woody G
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 2):66-72. PubMed ID: 22611701
[TBL] [Abstract][Full Text] [Related]
2. Injectable extended-release naltrexone for opioid dependence.
Woody GE; Metzger DS
Lancet; 2011 Aug; 378(9792):664-5; author reply 666. PubMed ID: 21856476
[No Abstract] [Full Text] [Related]
3. Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.
Krupitsky E; Nunes EV; Ling W; Gastfriend DR; Memisoglu A; Silverman BL
Addiction; 2013 Sep; 108(9):1628-37. PubMed ID: 23701526
[TBL] [Abstract][Full Text] [Related]
4. Naltrexone depot formulations for opioid and alcohol dependence: a systematic review.
Lobmaier PP; Kunøe N; Gossop M; Waal H
CNS Neurosci Ther; 2011 Dec; 17(6):629-36. PubMed ID: 21554565
[TBL] [Abstract][Full Text] [Related]
5. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
[TBL] [Abstract][Full Text] [Related]
6. [Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial].
Krupitskiĭ EM; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Blokhina EA; Silverman BL
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5 Pt 2):3-11. PubMed ID: 22951790
[TBL] [Abstract][Full Text] [Related]
7. Long-acting depot formulations of naltrexone for heroin dependence: a review.
Krupitsky EM; Blokhina EA
Curr Opin Psychiatry; 2010 May; 23(3):210-4. PubMed ID: 20224403
[TBL] [Abstract][Full Text] [Related]
8. Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available.
Krupitsky E; Zvartau E; Woody G
Curr Psychiatry Rep; 2010 Oct; 12(5):448-53. PubMed ID: 20640538
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone: Not Just for Opioids Anymore.
Sudakin D
J Med Toxicol; 2016 Mar; 12(1):71-5. PubMed ID: 26546222
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone implants -- duration, tolerability and clinical usefulness. A pilot study.
Waal H; Frogopsahl G; Olsen L; Christophersen AS; Mørland J
Eur Addict Res; 2006; 12(3):138-44. PubMed ID: 16778434
[TBL] [Abstract][Full Text] [Related]
11. [Injectable extended-release naltrexone for opioid dependence: an open label study of long-term safety and efficacy].
Krupitsky EM; Nunes EV; Ling W; Gastfriend DR; Memisoglu A; Blokhina EA; Silverman BL
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):49-56. PubMed ID: 25591636
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in naltrexone implants and depot injections for opiate abuse: the new kid on the block is approaching adulthood.
Brewer C; Streel E
Adicciones; 2010; 22(4):285-91. PubMed ID: 21152846
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of injectable, depot naltrexone for the relapse prevention treatment of opioid dependence.
Xuyi W; Juelu W; Xiaojun X; Haiyan L; Zheyuan L; Zhehui G; Guoming D; Gang L; Jin L; Wei H
Am J Addict; 2014; 23(2):162-9. PubMed ID: 24107112
[TBL] [Abstract][Full Text] [Related]
14. Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy.
Degenhardt L; Gibson A; Mattick RP; Hall W
Drug Alcohol Rev; 2008 Jan; 27(1):1-3. PubMed ID: 18034375
[No Abstract] [Full Text] [Related]
15. A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence.
Larney S; Gowing L; Mattick RP; Farrell M; Hall W; Degenhardt L
Drug Alcohol Rev; 2014 Mar; 33(2):115-28. PubMed ID: 24299657
[TBL] [Abstract][Full Text] [Related]
16. Injectable extended-release naltrexone for opioid dependence.
Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
Lancet; 2011 Aug; 378(9792):665; author reply 666. PubMed ID: 21856477
[No Abstract] [Full Text] [Related]
17. Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence.
Krupitsky E; Zvartau E; Blokhina E; Verbitskaya E; Wahlgren V; Tsoy-Podosenin M; Bushara N; Burakov A; Masalov D; Romanova T; Tyurina A; Palatkin V; Slavina T; Pecoraro A; Woody GE
Arch Gen Psychiatry; 2012 Sep; 69(9):973-81. PubMed ID: 22945623
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone-facilitated buprenorphine discontinuation: a feasibility trial.
Dakwar E; Kleber HD
J Subst Abuse Treat; 2015 Jun; 53():60-3. PubMed ID: 25819700
[TBL] [Abstract][Full Text] [Related]
19. Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?
Sullivan MA; Bisaga A; Mariani JJ; Glass A; Levin FR; Comer SD; Nunes EV
Drug Alcohol Depend; 2013 Nov; 133(1):80-5. PubMed ID: 23827259
[TBL] [Abstract][Full Text] [Related]
20. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
Hulse GK; Morris N; Arnold-Reed D; Tait RJ
Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]